{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Notice\" and posted_year = 2016 sorted by posted_date descending", "rows": [["FDA-2013-N-1155-0004", "FDA", "FDA-2013-N-1155", "Agency Information Collection Activities; Proposed Collection; Comment Request; Food Labeling Regulations", "Notice", "60 Day Proposed Information Collection", "2016-12-30T05:00:00Z", 2016, 12, "2016-12-30T05:00:00Z", "2017-03-01T04:59:59Z", "2017-04-26T12:10:50Z", "2016-31733", 0, 0, "0900006482441427"], ["FDA-2015-D-0025-0015", "FDA", "FDA-2015-D-0025", "Medical Device Accessories\u2014Describing Accessories and Classification Pathway for New Accessory Types; Guidance for Industry and Food and Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2016-12-30T05:00:00Z", 2016, 12, "2016-12-30T05:00:00Z", null, "2016-12-30T14:17:49Z", "2016-31669", 0, 0, "0900006482441379"], ["FDA-2013-N-0879-0004", "FDA", "FDA-2013-N-0879", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request: Procedures for Safe and Sanitary Processing and Importing of Fish and Fishery Products", "Notice", "30 Day Proposed Information Collection", "2016-12-29T05:00:00Z", 2016, 12, "2016-12-29T05:00:00Z", "2017-01-31T04:59:59Z", "2017-01-31T02:00:17Z", "2016-31424", 0, 0, "090000648243d253"], ["FDA-2016-D-4318-0001", "FDA", "FDA-2016-D-4318", "Compounding and Repackaging of Radiopharmaceuticals by State-\nLicensed Nuclear Pharmacies and Federal Facilities; Draft Guidance for\nIndustry; Availability", "Notice", "Notice of Availability", "2016-12-29T05:00:00Z", 2016, 12, "2016-12-29T05:00:00Z", null, "2016-12-29T14:29:37Z", "2016-31513", 0, 0, "090000648243d2fb"], ["FDA-2000-D-0103-0009", "FDA", "FDA-2000-D-0103", "Botanical Drug Development; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-12-29T05:00:00Z", 2016, 12, "2016-12-29T05:00:00Z", null, "2016-12-29T14:39:34Z", "2016-31627", 0, 0, "090000648243d468"], ["FDA-2009-D-0524-0032", "FDA", "FDA-2009-D-0524", "Listing of Ingredients in Tobacco Products; Revised Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-12-29T05:00:00Z", 2016, 12, "2016-12-29T05:00:00Z", null, "2016-12-29T15:34:59Z", "2016-31587", 0, 0, "090000648243d2a5"], ["FDA-2016-N-0002-0035", "FDA", "FDA-2016-N-0002", "Abbott Laboratories, et al.; Withdrawal of Approval of Four New Drug\nApplications and Two Abbreviated New Drug Applications", "Notice", "Withdrawal", "2016-12-29T05:00:00Z", 2016, 12, "2016-12-29T05:00:00Z", null, "2016-12-29T15:02:22Z", "2016-31625", 0, 0, "090000648243d2a9"], ["FDA-2016-D-2495-0013", "FDA", "FDA-2016-D-2495", "Submission of Warning Plans for Cigars; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-12-29T05:00:00Z", 2016, 12, "2016-12-29T05:00:00Z", null, "2016-12-29T14:48:32Z", "2016-31586", 0, 0, "090000648243d469"], ["FDA-2014-D-0234-0029", "FDA", "FDA-2014-D-0234", "Clinical Pharmacology Data To Support a Demonstration of Biosimilarity to a Reference Product; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-12-29T05:00:00Z", 2016, 12, "2016-12-29T05:00:00Z", null, "2016-12-29T14:18:33Z", "2016-31511", 0, 0, "090000648243d24e"], ["FDA-2016-D-0269-0112", "FDA", "FDA-2016-D-0269", "Prescription Requirement Under Section 503A of the Federal Food,\nDrug, and Cosmetic Act; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-12-29T05:00:00Z", 2016, 12, "2016-12-29T05:00:00Z", null, "2016-12-29T14:33:49Z", "2016-31607", 0, 0, "090000648243d35a"], ["FDA-2016-D-4317-0001", "FDA", "FDA-2016-D-4317", "Compounding and Repackaging of Radiopharmaceuticals by Outsourcing Facilities; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-12-29T05:00:00Z", 2016, 12, "2016-12-29T05:00:00Z", null, "2016-12-29T14:53:06Z", "2016-31512", 0, 0, "090000648243d4ab"], ["FDA-2016-N-0001-0129", "FDA", "FDA-2016-N-0001", "Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-Based Products; Public Workshop", "Notice", "Public Meetings", "2016-12-29T05:00:00Z", 2016, 12, "2016-12-29T05:00:00Z", null, "2016-12-29T14:11:28Z", "2016-31628", 0, 0, "090000648243d171"], ["FDA-2014-D-1953-0002", "FDA", "FDA-2014-D-1953", "Providing Regulatory Submissions in Electronic Format\u2014Submission of\nManufacturing Establishment Information; Draft Guidance for Industry; Availability", "Notice", null, "2016-12-29T00:00:00Z", 2016, 12, null, null, "2019-05-22T14:57:37Z", null, 0, 1, "090000648243d173"], ["FDA-2016-E-1179-0006", "FDA", "FDA-2016-E-1179", "Determinations of Regulatory Review Periods for Purposes of Patent Extensions: IMLYGIC", "Notice", "Determinations", "2016-12-28T05:00:00Z", 2016, 12, "2016-12-28T05:00:00Z", "2017-06-27T03:59:59Z", "2016-12-28T14:27:41Z", "2016-31322", 0, 0, "090000648243a972"], ["FDA-2016-E-1182-0006", "FDA", "FDA-2016-E-1182", "Determinations of Regulatory Review Periods for Purposes of Patent Extensions: IMLYGIC", "Notice", "Determinations", "2016-12-28T05:00:00Z", 2016, 12, "2016-12-28T05:00:00Z", "2017-06-27T03:59:59Z", "2016-12-28T14:20:56Z", "2016-31322", 0, 0, "0900006482439ffb"], ["FDA-2010-N-0067-0003", "FDA", "FDA-2010-N-0067", "Pharmaceutical Science and Clinical Pharmacology Advisory Committee;\nNotice of Meeting; Correction", "Notice", "Correction", "2016-12-28T05:00:00Z", 2016, 12, "2016-12-28T05:00:00Z", null, "2016-12-28T14:16:07Z", "2016-31391", 0, 0, "0900006482439e88"], ["FDA-2016-E-1181-0006", "FDA", "FDA-2016-E-1181", "Determinations of Regulatory Review Periods for Purposes of Patent Extensions: IMLYGIC", "Notice", "Determinations", "2016-12-28T05:00:00Z", 2016, 12, "2016-12-28T05:00:00Z", "2017-06-27T03:59:59Z", "2016-12-28T14:27:57Z", "2016-31322", 0, 0, "090000648243a973"], ["FDA-2015-D-5105-0057", "FDA", "FDA-2015-D-5105", "Postmarket Management of Cybersecurity in Medical Devices; Guidance for Industry and Food and Drug Administration; Availability", "Notice", "Notice of Availability", "2016-12-28T05:00:00Z", 2016, 12, "2016-12-28T05:00:00Z", null, "2016-12-28T14:24:37Z", "2016-31406", 0, 0, "090000648243a197"], ["FDA-2016-N-4187-0001", "FDA", "FDA-2016-N-4187", "Coordinated Registry Network for Devices Used for Acute Ischemic Stroke Intervention; Public Workshop; Request for Comments", "Notice", "Public Meetings", "2016-12-27T05:00:00Z", 2016, 12, "2016-12-27T05:00:00Z", "2017-03-03T04:59:59Z", "2017-03-03T02:01:15Z", "2016-31143", 0, 0, "090000648243741a"], ["FDA-2016-N-0001-0128", "FDA", "FDA-2016-N-0001", "Psychopharmacologic Drugs Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2016-12-27T05:00:00Z", 2016, 12, "2016-12-27T05:00:00Z", null, "2016-12-27T13:46:42Z", "2016-31144", 0, 0, "09000064824373d0"], ["FDA-2016-D-1495-0014", "FDA", "FDA-2016-D-1495", "Factors to Consider Regarding Benefit-Risk in Medical Device Product Availability, Compliance, and Enforcement Decisions; Guidance for Industry and Food and Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2016-12-27T05:00:00Z", 2016, 12, "2016-12-27T05:00:00Z", null, "2016-12-27T15:04:22Z", "2016-31145", 0, 0, "0900006482437595"], ["FDA-2012-N-1021-0033", "FDA", "FDA-2012-N-1021", "Medical Device User Fee and Modernization Act; Notice to Public of\nWeb Site Location of Fiscal Year 2017 Proposed Guidance Development", "Notice", "Announcement", "2016-12-23T05:00:00Z", 2016, 12, "2016-12-23T05:00:00Z", "2017-02-22T04:59:59Z", "2019-10-15T14:26:03Z", "2016-31006", 0, 0, "0900006482433eae"], ["FDA-2016-N-4342-0001", "FDA", "FDA-2016-N-4342", "Agency Information Collection Activities; Proposed Collection; Comment Request; Application for Participation in the Food and Drug Administration Regulatory Science Student Internship Program", "Notice", "60 Day Proposed Information Collection", "2016-12-23T05:00:00Z", 2016, 12, "2016-12-23T05:00:00Z", "2017-02-22T04:59:59Z", "2016-12-23T14:37:29Z", "2016-30967", 0, 0, "0900006482433da8"], ["FDA-2016-N-4319-0001", "FDA", "FDA-2016-N-4319", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Unique Device\nIdentification System", "Notice", "30 Day Proposed Information Collection", "2016-12-23T05:00:00Z", 2016, 12, "2016-12-23T05:00:00Z", "2017-01-24T04:59:59Z", "2016-12-23T14:30:43Z", "2016-30966", 0, 0, "0900006482433811"], ["FDA-2007-D-0369-0399", "FDA", "FDA-2007-D-0369", "Product-Specific Bioequivalence Recommendations; Draft and Revised\nDraft Guidances for Industry; Availability", "Notice", "Notice of Availability", "2016-12-23T05:00:00Z", 2016, 12, "2016-12-23T05:00:00Z", "2017-02-22T04:59:59Z", "2017-03-08T02:01:43Z", "2016-30984", 0, 0, "09000064824338b3"], ["FDA-2004-N-0451-0040", "FDA", "FDA-2004-N-0451", "Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 046", "Notice", "Announcement", "2016-12-23T05:00:00Z", 2016, 12, "2016-12-23T05:00:00Z", null, "2016-12-23T14:47:43Z", "2016-31008", 0, 0, "0900006482433ef3"], ["FDA-2016-N-2474-0002", "FDA", "FDA-2016-N-2474", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Reporting\nAssociated With Designated New Animal Drugs for Minor Use and Minor\nSpecies", "Notice", "30 Day Proposed Information Collection", "2016-12-22T05:00:00Z", 2016, 12, "2016-12-22T05:00:00Z", "2017-01-24T04:59:59Z", "2016-12-22T14:46:45Z", "2016-30770", 0, 0, "090000648243058b"], ["FDA-2014-D-2275-0001", "FDA", "FDA-2014-D-2275", "Lead in Cosmetic Lip Products and Externally Applied Cosmetics:\nRecommended Maximum Level; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-12-22T05:00:00Z", 2016, 12, "2016-12-22T05:00:00Z", null, "2016-12-22T14:49:34Z", "2016-30781", 0, 0, "0900006482430288"], ["FDA-2010-N-0597-0005", "FDA", "FDA-2010-N-0597", "Agency Information Collection Activities; Proposed Collection; Comment Request; Index of Legally Marketed Unapproved New Animal Drugs \nfor Minor Species", "Notice", "60 Day Proposed Information Collection", "2016-12-21T05:00:00Z", 2016, 12, "2016-12-21T05:00:00Z", "2017-02-22T04:59:59Z", "2017-02-08T14:02:51Z", "2016-30676", 0, 0, "090000648242d101"], ["FDA-2016-N-4320-0001", "FDA", "FDA-2016-N-4320", "Sun Pharmaceutical Industries, Inc.; Withdrawal of Approval of 28\nAbbreviated New Drug Applications", "Notice", "Withdrawal", "2016-12-20T05:00:00Z", 2016, 12, "2016-12-20T05:00:00Z", null, "2016-12-20T14:56:31Z", "2016-30623", 0, 0, "09000064824290f9"], ["FDA-2016-D-0620-0003", "FDA", "FDA-2016-D-0620", "Question-Based Review for the Chemistry, Manufacturing, and Controls Technical Section of Animal Drug Applications; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-12-20T05:00:00Z", 2016, 12, "2016-12-20T05:00:00Z", null, "2016-12-20T14:52:21Z", "2016-30613", 0, 0, "09000064824290f3"], ["FDA-2016-E-0626-0006", "FDA", "FDA-2016-E-0626", "Determinations of Regulatory Review Periods for Purposes of Patent Extensions: COSENTYX", "Notice", "Determinations", "2016-12-20T05:00:00Z", 2016, 12, "2016-12-20T05:00:00Z", "2017-06-20T03:59:59Z", "2016-12-20T14:49:29Z", "2016-30528", 0, 0, "09000064824290f2"], ["FDA-2016-N-0969-0003", "FDA", "FDA-2016-N-0969", "Authorization of Emergency Use of an In Vitro Diagnostic Device for\nDetection of Zika Virus; Availability", "Notice", "Announcement", "2016-12-20T05:00:00Z", 2016, 12, "2016-12-20T05:00:00Z", null, "2016-12-20T14:59:56Z", "2016-30532", 0, 0, "090000648242960c"], ["FDA-2012-N-0873-0007", "FDA", "FDA-2012-N-0873", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2016-12-19T05:00:00Z", 2016, 12, "2016-12-19T05:00:00Z", null, "2016-12-19T15:45:14Z", "2016-30351", 0, 0, "09000064824264ce"], ["FDA-2016-N-1593-0002", "FDA", "FDA-2016-N-1593", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2016-12-19T05:00:00Z", 2016, 12, "2016-12-19T05:00:00Z", null, "2016-12-19T15:47:32Z", "2016-30351", 0, 0, "09000064824264d5"], ["FDA-2015-N-2406-0009", "FDA", "FDA-2015-N-2406", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2016-12-19T05:00:00Z", 2016, 12, "2016-12-19T05:00:00Z", null, "2016-12-19T15:48:15Z", "2016-30351", 0, 0, "09000064824264d6"], ["FDA-2013-N-0450-0006", "FDA", "FDA-2013-N-0450", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2016-12-19T05:00:00Z", 2016, 12, "2016-12-19T05:00:00Z", null, "2016-12-19T15:48:56Z", "2016-30351", 0, 0, "09000064824264f0"], ["FDA-2011-N-0830-0030", "FDA", "FDA-2011-N-0830", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2016-12-19T05:00:00Z", 2016, 12, "2016-12-19T05:00:00Z", null, "2016-12-19T15:32:16Z", "2016-30351", 0, 0, "0900006482423485"], ["FDA-2013-N-0093-0010", "FDA", "FDA-2013-N-0093", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2016-12-19T05:00:00Z", 2016, 12, "2016-12-19T05:00:00Z", null, "2016-12-19T15:47:08Z", "2016-30351", 0, 0, "09000064824264d4"], ["FDA-2015-E-3157-0005", "FDA", "FDA-2015-E-3157", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; TRULICITY", "Notice", "Determinations", "2016-12-19T05:00:00Z", 2016, 12, "2016-12-19T05:00:00Z", "2017-06-20T03:59:59Z", "2016-12-19T15:35:53Z", "2016-30399", 0, 0, "0900006482423949"], ["FDA-2013-N-0242-0009", "FDA", "FDA-2013-N-0242", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2016-12-19T05:00:00Z", 2016, 12, "2016-12-19T05:00:00Z", null, "2016-12-19T15:46:13Z", "2016-30351", 0, 0, "09000064824264d1"], ["FDA-2008-D-0031-0005", "FDA", "FDA-2008-D-0031", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2016-12-19T05:00:00Z", 2016, 12, "2016-12-19T05:00:00Z", null, "2016-12-19T15:45:42Z", "2016-30351", 0, 0, "09000064824264d0"], ["FDA-2013-N-0125-0024", "FDA", "FDA-2013-N-0125", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2016-12-19T05:00:00Z", 2016, 12, "2016-12-19T05:00:00Z", null, "2016-12-19T15:46:41Z", "2016-30351", 0, 0, "09000064824264d3"], ["FDA-2015-D-4361-0005", "FDA", "FDA-2015-D-4361", "Gifts to the Food and Drug Administration: Evaluation and Acceptance; Guidance for the Public and Food and Drug Administration; Availability", "Notice", "Notice of Availability", "2016-12-16T05:00:00Z", 2016, 12, "2016-12-16T05:00:00Z", null, "2016-12-16T15:05:07Z", "2016-30312", 0, 0, "0900006482414334"], ["FDA-2014-D-1352-0005", "FDA", "FDA-2014-D-1352", "International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Bioequivalence: Blood Level Bioequivalence Study; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-12-16T05:00:00Z", 2016, 12, "2016-12-16T05:00:00Z", null, "2016-12-16T15:12:36Z", "2016-30309", 0, 0, "0900006482414488"], ["FDA-2016-N-3995-0001", "FDA", "FDA-2016-N-3995", "Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices; Pediatric Uses of Devices; Requirement for Submission of Information on Pediatric Subpopulations That Suffer From a Disease or Condition That a Device Is Intended To Treat, Diagnose, or Cure", "Notice", "60 Day Proposed Information Collection", "2016-12-16T05:00:00Z", 2016, 12, "2016-12-16T05:00:00Z", "2017-02-15T04:59:59Z", "2016-12-16T15:15:37Z", "2016-30243", 0, 0, "0900006482414962"], ["FDA-2015-D-0390-0025", "FDA", "FDA-2015-D-0390", "Use of Electronic Informed Consent\u2014Questions and Answers; Guidance for Institutional Review Boards, Investigators, and Sponsors; Availability", "Notice", "Notice of Availability", "2016-12-15T05:00:00Z", 2016, 12, "2016-12-15T05:00:00Z", null, "2016-12-15T15:09:26Z", "2016-30146", 0, 0, "090000648240b6b5"], ["FDA-2013-N-0795-0005", "FDA", "FDA-2013-N-0795", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Medical Devices;\nThird-Party Review Under the Food and Drug Administration  Modernization Act", "Notice", "30 Day Proposed Information Collection", "2016-12-15T05:00:00Z", 2016, 12, "2016-12-15T05:00:00Z", "2017-01-18T04:59:59Z", "2016-12-15T14:59:29Z", "2016-30113", 0, 0, "090000648240b585"], ["FDA-2016-N-4119-0001", "FDA", "FDA-2016-N-4119", "Food Safety Modernization Act Third-Party Certification Program User Fee\nRate for Fiscal Year 2017", "Notice", "Announcement", "2016-12-14T05:00:00Z", 2016, 12, "2016-12-14T05:00:00Z", null, "2016-12-14T14:50:58Z", "2016-30034", 0, 0, "090000648240749a"], ["FDA-2016-N-4198-0001", "FDA", "FDA-2016-N-4198", "Public Meeting on Patient-Focused Drug Development for Sarcopenia;\nRequest for Comments", "Notice", "Request for Comments", "2016-12-14T05:00:00Z", 2016, 12, "2016-12-14T05:00:00Z", "2017-06-07T03:59:59Z", "2017-06-07T01:02:42Z", "2016-29998", 0, 0, "0900006482407424"], ["FDA-2012-N-0477-0008", "FDA", "FDA-2012-N-0477", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2016-12-14T05:00:00Z", 2016, 12, "2016-12-14T05:00:00Z", null, "2016-12-14T16:05:49Z", "2016-30035", 0, 0, "0900006482408288"], ["FDA-2016-D-4120-0001", "FDA", "FDA-2016-D-4120", "Fruit Juice and Vegetable Juice as Color Additives in Food; Draft\nGuidance for Industry; Availability", "Notice", "Notice of Availability", "2016-12-14T05:00:00Z", 2016, 12, "2016-12-14T05:00:00Z", "2017-02-14T04:59:59Z", "2017-02-14T02:00:19Z", "2016-29968", 0, 0, "0900006482407498"], ["FDA-2013-N-0662-0006", "FDA", "FDA-2013-N-0662", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2016-12-14T05:00:00Z", 2016, 12, "2016-12-14T05:00:00Z", null, "2016-12-14T16:05:07Z", "2016-30035", 0, 0, "0900006482408286"], ["FDA-2013-N-0519-0006", "FDA", "FDA-2013-N-0519", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2016-12-14T05:00:00Z", 2016, 12, "2016-12-14T05:00:00Z", null, "2016-12-14T14:45:15Z", "2016-30035", 0, 0, "0900006482407453"], ["FDA-2009-N-0511-0006", "FDA", "FDA-2009-N-0511", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2016-12-14T05:00:00Z", 2016, 12, "2016-12-14T05:00:00Z", null, "2016-12-14T16:02:32Z", "2016-30035", 0, 0, "090000648240823d"], ["FDA-2013-N-0134-0005", "FDA", "FDA-2013-N-0134", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2016-12-14T05:00:00Z", 2016, 12, "2016-12-14T05:00:00Z", null, "2016-12-14T16:02:06Z", "2016-30035", 0, 0, "090000648240823b"], ["FDA-2013-N-0450-0005", "FDA", "FDA-2013-N-0450", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2016-12-14T05:00:00Z", 2016, 12, "2016-12-14T05:00:00Z", null, "2016-12-14T16:05:28Z", "2016-30035", 0, 0, "0900006482408287"], ["FDA-2013-N-0375-0005", "FDA", "FDA-2013-N-0375", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2016-12-14T05:00:00Z", 2016, 12, "2016-12-14T05:00:00Z", null, "2016-12-14T16:01:21Z", "2016-30035", 0, 0, "0900006482408237"], ["FDA-2013-N-0370-0005", "FDA", "FDA-2013-N-0370", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2016-12-14T05:00:00Z", 2016, 12, "2016-12-14T05:00:00Z", null, "2016-12-14T16:01:43Z", "2016-30035", 0, 0, "0900006482408238"], ["FDA-2011-N-0902-0009", "FDA", "FDA-2011-N-0902", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2016-12-14T05:00:00Z", 2016, 12, "2016-12-14T05:00:00Z", null, "2016-12-14T16:04:45Z", "2016-30035", 0, 0, "0900006482408240"], ["FDA-1997-N-0020-0194", "FDA", "FDA-1997-N-0020", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2016-12-14T05:00:00Z", 2016, 12, "2016-12-14T05:00:00Z", null, "2016-12-14T16:04:21Z", "2016-30035", 0, 0, "090000648240823f"], ["FDA-2015-D-4803-0030", "FDA", "FDA-2015-D-4803", "Public Notification of Emerging Postmarket Medical Device Signals\n(\u2018\u2018Emerging Signals\u2019\u2019); Guidance for Industry and Food and Drug\nAdministration Staff; Availability", "Notice", "Notice of Availability", "2016-12-14T05:00:00Z", 2016, 12, "2016-12-14T05:00:00Z", null, "2016-12-14T14:56:12Z", "2016-29989", 0, 0, "0900006482407d7e"], ["FDA-2016-N-2836-0008", "FDA", "FDA-2016-N-2836", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Donor Risk\nAssessment Questionnaire for the Food and Drug Administration/National Heart, Lung, and Blood Institute-Sponsored Transfusion-Transmissible Infections Monitoring System\u2014Risk Factor Elicitation", "Notice", "30 Day Proposed Information Collection", "2016-12-13T05:00:00Z", 2016, 12, "2016-12-13T05:00:00Z", "2017-01-13T04:59:59Z", "2019-12-27T18:27:32Z", "2016-29814", 0, 0, "09000064823fed94"], ["FDA-2009-D-0508-0014", "FDA", "FDA-2009-D-0508", "Registration and Product Listing for Owners and Operators of Domestic\nTobacco Product Establishment; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-12-13T05:00:00Z", 2016, 12, "2016-12-13T05:00:00Z", null, "2016-12-13T14:22:26Z", "2016-29776", 0, 0, "09000064823fe52b"], ["FDA-2016-E-0625-0005", "FDA", "FDA-2016-E-0625", "Determinations of Regulatory Review Periods for Purposes of Patent Extensions: NUCALA", "Notice", "Determinations", "2016-12-13T05:00:00Z", 2016, 12, "2016-12-13T05:00:00Z", "2017-06-13T03:59:59Z", "2016-12-13T14:24:15Z", "2016-29838", 0, 0, "09000064823fe725"], ["FDA-2013-N-0764-0009", "FDA", "FDA-2013-N-0764", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Animal Feed\nRegulatory Program Standards", "Notice", "30 Day Proposed Information Collection", "2016-12-13T05:00:00Z", 2016, 12, "2016-12-13T05:00:00Z", "2017-01-13T04:59:59Z", "2016-12-13T14:27:29Z", "2016-29839", 0, 0, "09000064823fed90"], ["FDA-2016-P-1363-0005", "FDA", "FDA-2016-P-1363", "Determination That SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER \n(Sodium Chloride), Injectable, 234 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "Determinations", "2016-12-12T05:00:00Z", 2016, 12, "2016-12-12T05:00:00Z", null, "2016-12-12T14:18:25Z", "2016-29674", 0, 0, "09000064823f9857"], ["FDA-2000-D-0128-0003", "FDA", "FDA-2000-D-0128", "Medical Devices: Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test Systems; Guidance for Industry and FDA; Availability", "Notice", "Notice of Availability", "2016-12-12T05:00:00Z", 2016, 12, "2016-12-12T05:00:00Z", null, "2016-12-13T02:01:35Z", null, 0, 0, "09000064823fc479"], ["FDA-2016-D-3466-0001", "FDA", "FDA-2016-D-3466", "Immediately in Effect Guidance Document: Conditions for Sale for Air-Conduction Hearing Aids; Guidance for Industry and Food and Drug \nAdministration Staff; Availability", "Notice", "Notice of Availability", "2016-12-12T05:00:00Z", 2016, 12, "2016-12-12T05:00:00Z", null, "2016-12-12T13:46:11Z", "2016-29724", 0, 0, "09000064823f97ff"], ["FDA-2016-D-1814-0001", "FDA", "FDA-2016-D-1814", "Preparation of Food Contact Notifications for Food Contact Substances in Contact With Infant Formula and/or Human Milk; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-12-09T05:00:00Z", 2016, 12, "2016-12-09T05:00:00Z", "2017-02-08T04:59:59Z", "2017-02-08T02:04:29Z", "2016-29587", 0, 0, "09000064823f44a8"], ["FDA-2014-D-0609-0022", "FDA", "FDA-2014-D-0609", "Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-12-09T05:00:00Z", 2016, 12, "2016-12-09T05:00:00Z", null, "2025-04-01T16:32:50Z", "2016-29588", 0, 0, "09000064823f4a40"], ["FDA-2016-N-4096-0001", "FDA", "FDA-2016-N-4096", "Final Assessment of the Program for Enhanced Review Transparency and Communication; Public Meeting and Establishment of Docket", "Notice", "Announcement", "2016-12-09T05:00:00Z", 2016, 12, "2016-12-09T05:00:00Z", "2017-04-04T03:59:59Z", "2017-04-04T13:00:45Z", "2016-29589", 0, 0, "09000064823f4bfc"], ["FDA-2011-N-0146-0239", "FDA", "FDA-2011-N-0146", "Third-Party Certification Body Accreditation for Food Safety Audits:  Model Accreditation Standards; Guidance for Industry and Food and Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2016-12-07T05:00:00Z", 2016, 12, "2016-12-07T05:00:00Z", null, "2016-12-07T16:14:15Z", "2016-29278", 0, 0, "09000064823e6ef0"], ["FDA-2016-E-0630-0005", "FDA", "FDA-2016-E-0630", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; GARDASIL 9", "Notice", "Determinations", "2016-12-07T05:00:00Z", 2016, 12, "2016-12-07T05:00:00Z", "2017-02-07T04:59:59Z", "2016-12-07T14:56:23Z", "2016-29303", 0, 0, "09000064823e7947"], ["FDA-2016-N-3274-0001", "FDA", "FDA-2016-N-3274", "Posting Adverse Event Report Data Associated With Conventional Foods,\nDietary Supplements, and Cosmetics on the Internet; Availability", "Notice", "Notice of Availability", "2016-12-07T05:00:00Z", 2016, 12, "2016-12-07T05:00:00Z", null, "2016-12-07T14:52:14Z", "2016-29277", 0, 0, "09000064823e6fa0"], ["FDA-2016-E-1102-0003", "FDA", "FDA-2016-E-1102", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; GARDASIL 9", "Notice", "Determinations", "2016-12-07T05:00:00Z", 2016, 12, "2016-12-07T05:00:00Z", "2017-02-07T04:59:59Z", "2016-12-07T14:55:45Z", "2016-29303", 0, 0, "09000064823e7105"], ["FDA-2013-D-0117-0006", "FDA", "FDA-2013-D-0117", "Agency Information Collection Activities; Proposed Collection; Comment Request; Providing Information About Pediatric Uses of Medical Devices", "Notice", "60 Day Proposed Information Collection", "2016-12-05T05:00:00Z", 2016, 12, "2016-12-05T05:00:00Z", "2017-02-04T04:59:59Z", "2016-12-05T16:11:40Z", "2016-29105", 0, 0, "09000064823ded6b"], ["FDA-1999-D-1875-0024", "FDA", "FDA-1999-D-1875", "Compliance Policy Guide Sec. 615.115 on Extralabel Use of Medicated Feeds\nfor Minor Species; Availability", "Notice", "Notice of Availability", "2016-12-05T05:00:00Z", 2016, 12, "2016-12-05T05:00:00Z", null, "2016-12-05T16:29:04Z", "2016-29133", 0, 0, "09000064823def04"], ["FDA-2013-N-1089-0004", "FDA", "FDA-2013-N-1089", "Agency Information Collection Activities; Proposed Collection; Comment Request; Recommended Glossary and Educational Outreach To Support Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use", "Notice", "60 Day Proposed Information Collection", "2016-12-05T05:00:00Z", 2016, 12, "2016-12-05T05:00:00Z", "2017-02-04T04:59:59Z", "2016-12-05T16:32:01Z", "2016-29104", 0, 0, "09000064823def94"], ["FDA-2016-N-2544-0002", "FDA", "FDA-2016-N-2544", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Medical Device:\nCurrent Good Manufacturing Practice Quality System Regulations", "Notice", "30 Day Proposed Information Collection", "2016-12-05T05:00:00Z", 2016, 12, "2016-12-05T05:00:00Z", "2017-01-05T04:59:59Z", "2016-12-05T16:16:22Z", "2016-29028", 0, 0, "09000064823dedfc"], ["FDA-2016-E-0617-0005", "FDA", "FDA-2016-E-0617", "Determinations of Regulatory Review Periods for Purposes of Patent Extension: BEXSERO", "Notice", "Determinations", "2016-12-05T05:00:00Z", 2016, 12, "2016-12-05T05:00:00Z", "2017-06-06T03:59:59Z", "2016-12-05T16:32:55Z", "2016-29025", 0, 0, "09000064823e018b"], ["FDA-2016-N-2896-0004", "FDA", "FDA-2016-N-2896", "Public Meeting on Pre-Market Evaluation of Abuse-Deterrent Properties of Opioid Drug Products; Extension of Comment Period", "Notice", "Extension of Comment Period", "2016-12-05T05:00:00Z", 2016, 12, "2016-12-05T05:00:00Z", "2017-01-04T04:59:59Z", "2017-01-04T02:00:17Z", "2016-29097", 0, 0, "09000064823ded68"], ["FDA-2016-E-0619-0005", "FDA", "FDA-2016-E-0619", "Determinations of Regulatory Review Periods for Purposes of Patent Extension: BEXSERO", "Notice", "Determinations", "2016-12-05T05:00:00Z", 2016, 12, "2016-12-05T05:00:00Z", "2017-06-06T03:59:59Z", "2016-12-05T16:22:30Z", "2016-29025", 0, 0, "09000064823deeab"], ["FDA-2009-D-0095-0015", "FDA", "FDA-2009-D-0095", "Clinical Pharmacology Section of Labeling for Human Prescription Drug\nand Biological Products\u2014Content and Format; Guidance for Industry;\nAvailability", "Notice", "Notice of Availability", "2016-12-05T05:00:00Z", 2016, 12, "2016-12-05T05:00:00Z", null, "2016-12-05T16:25:46Z", "2016-29125", 0, 0, "09000064823deeb0"], ["FDA-2009-D-0600-0019", "FDA", "FDA-2009-D-0600", "Health Document Submission Requirements for Tobacco Products;\nGuidance for Industry; Availability", "Notice", "Notice of Availability", "2016-12-05T05:00:00Z", 2016, 12, "2016-12-05T05:00:00Z", null, "2016-12-05T15:39:55Z", "2016-29117", 0, 0, "09000064823ded63"], ["FDA-2015-E-3159-0004", "FDA", "FDA-2015-E-3159", "Determination of Regulatory Review Period for Purposes of Patent Extension; TRUMENBA", "Notice", "Determinations", "2016-12-02T05:00:00Z", 2016, 12, "2016-12-02T05:00:00Z", "2017-06-01T03:59:59Z", "2016-12-02T17:20:09Z", "2016-28916", 0, 0, "09000064823db1ad"], ["FDA-2016-E-0616-0005", "FDA", "FDA-2016-E-0616", "Determination of Regulatory Review Period for Purposes of Patent Extension; OPDIVO", "Notice", "Determinations", "2016-12-02T05:00:00Z", 2016, 12, "2016-12-02T05:00:00Z", "2017-06-01T03:59:59Z", "2016-12-02T17:04:55Z", "2016-28917", 0, 0, "09000064823da02e"], ["FDA-2015-E-5107-0004", "FDA", "FDA-2015-E-5107", "Determination of Regulatory Review Period for Purposes of Patent Extension; TRESIBA", "Notice", "Determinations", "2016-12-02T05:00:00Z", 2016, 12, "2016-12-02T05:00:00Z", "2017-06-01T03:59:59Z", "2016-12-02T16:58:01Z", "2016-28939", 0, 0, "09000064823d9ecd"], ["FDA-2015-E-3158-0004", "FDA", "FDA-2015-E-3158", "Determination of Regulatory Review Period for Purposes of Patent Extension; TRUMENBA", "Notice", "Determinations", "2016-12-02T05:00:00Z", 2016, 12, "2016-12-02T05:00:00Z", "2017-06-01T03:59:59Z", "2016-12-02T17:14:07Z", "2016-28916", 0, 0, "09000064823da076"], ["FDA-2016-D-3969-0001", "FDA", "FDA-2016-D-3969", "Physiologically Based Pharmacokinetic Analyses--Format and Content; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-12-02T05:00:00Z", 2016, 12, "2016-12-02T05:00:00Z", "2017-02-01T04:59:59Z", "2017-02-01T02:02:41Z", "2016-28971", 0, 0, "09000064823da07b"], ["FDA-2016-D-2635-0125", "FDA", "FDA-2016-D-2635", "The Judicious Use of Medically Important Antimicrobial Drugs in Food-\nProducing Animals; Establishing Appropriate Durations of Therapeutic\nAdministration; Extension of Comment\nPeriod", "Notice", "Extension of Comment Period", "2016-11-29T05:00:00Z", 2016, 11, "2016-11-29T05:00:00Z", "2017-03-14T03:59:59Z", "2017-03-22T01:02:45Z", "2016-28660", 0, 0, "09000064823c5eee"], ["FDA-2016-F-3880-0001", "FDA", "FDA-2016-F-3880", "Novus International, Inc.; Filing of Food Additive Petition (Animal Use);\nCorrection", "Notice", "Correction", "2016-11-29T05:00:00Z", 2016, 11, "2016-11-29T05:00:00Z", null, "2016-11-29T14:42:23Z", "2016-28656", 0, 0, "09000064823c5ea5"], ["FDA-2014-D-2153-0012", "FDA", "FDA-2014-D-2153", "Mitigating the Risk of Cross-Contamination From Valves and Accessories Used for Irrigation Through Flexible Gastrointestinal Endoscopes;  Guidance for Industry and Food and Drug Administration Staff;  Availability", "Notice", "Notice of Availability", "2016-11-29T05:00:00Z", 2016, 11, "2016-11-29T05:00:00Z", null, "2016-11-29T15:27:12Z", "2016-28604", 0, 0, "09000064823c5eed"], ["FDA-2016-N-0735-0026", "FDA", "FDA-2016-N-0735", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Superimposed\nText in Direct-to-Consumer Promotion of Prescription Drugs", "Notice", "30 Day Proposed Information Collection", "2016-11-29T05:00:00Z", 2016, 11, "2016-11-29T05:00:00Z", "2016-12-30T04:59:59Z", "2016-12-02T02:01:55Z", "2016-28733", 0, 0, "09000064823c5eef"], ["FDA-2013-D-0575-0033", "FDA", "FDA-2013-D-0575", "Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on Expedited Programs for Serious Conditions\u2014Drugs and Biologics", "Notice", "60 Day Proposed Information Collection", "2016-11-29T05:00:00Z", 2016, 11, "2016-11-29T05:00:00Z", "2017-01-31T04:59:59Z", "2016-11-29T15:05:48Z", "2016-28732", 0, 0, "09000064823c5ea9"], ["FDA-2015-E-4669-0004", "FDA", "FDA-2015-E-4669", "Determination of Regulatory Review Period for Purposes of Patent  Extension; IXINITY", "Notice", "Determinations", "2016-11-29T05:00:00Z", 2016, 11, "2016-11-29T05:00:00Z", "2017-05-31T03:59:59Z", "2016-11-29T16:20:41Z", "2016-28653", 0, 0, "09000064823c693a"], ["FDA-2011-N-0830-0029", "FDA", "FDA-2011-N-0830", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approval; Abbreviated New Drug Applications\nand 505(b)(2) Applications", "Notice", "Notice of Approval", "2016-11-29T05:00:00Z", 2016, 11, "2016-11-29T05:00:00Z", null, "2016-11-29T16:14:37Z", "2016-28655", 0, 0, "09000064823c607f"], ["FDA-2015-E-4659-0004", "FDA", "FDA-2015-E-4659", "Determination of Regulatory Review Period for Purposes of Patent  Extension; IXINITY", "Notice", "Determinations", "2016-11-29T05:00:00Z", 2016, 11, "2016-11-29T05:00:00Z", "2017-05-31T03:59:59Z", "2016-11-29T14:56:12Z", "2016-28653", 0, 0, "09000064823c5ea6"], ["FDA-2010-N-0067-0002", "FDA", "FDA-2010-N-0067", "Pharmaceutical Science and Clinical Pharmacology Advisory Committee;\nEstablishment of a Public Docket; Request for Comments; Notice of\nMeeting", "Notice", "Request for Comments", "2016-11-29T05:00:00Z", 2016, 11, "2016-11-29T05:00:00Z", "2017-04-15T03:59:59Z", "2017-04-15T01:02:05Z", "2016-28605", 0, 0, "09000064823c6040"], ["FDA-2013-D-0349-0010", "FDA", "FDA-2013-D-0349", "Providing Postmarketing Periodic Safety Reports in the International\nCouncil for Harmonisation E2C(R2) Format (Periodic Benefit-Risk\nEvaluation Report); Guidance for Industry; Availability", "Notice", "Notice of Availability", "2016-11-29T05:00:00Z", 2016, 11, "2016-11-29T05:00:00Z", null, "2016-11-29T15:53:39Z", "2016-28606", 0, 0, "09000064823c5f73"]], "truncated": false, "filtered_table_rows_count": 1014, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Notice", "p2": "2016"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2016", "results": [{"value": "FDA", "label": "FDA", "count": 1014, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Notice&posted_year=2016", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2016", "results": [{"value": "Notice", "label": "Notice", "count": 1014, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2016", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2016", "results": [{"value": 2016, "label": 2016, "count": 1014, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2016&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2016&_facet=open_for_comment"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2016&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2016&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2016&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2016&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2016&_facet_date=last_modified"}], "next": "2016-11-29T05~3A00~3A00Z,FDA-2013-D-0349-0010", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2016&_next=2016-11-29T05~3A00~3A00Z%2CFDA-2013-D-0349-0010&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 683.6644550203346, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}